ViaLase completed enrollment in the VIA-002 pivotal trial investigating femtosecond laser image-guided high-precision trabeculotomy for the treatment of primary open-angle glaucoma, according to a press release.
“Just as the femtosecond laser forever changed the landscape of refractive surgery, the prospect of the ViaLase platform doing the same as a glaucoma intervention is truly exciting,” William F. Wiley, MD, medical director at the Cleveland Eye Clinic, told Healio.
In the prospective, controlled, multicenter trial, 152 adult patients with primary open-angle glaucoma were